 | • レポートコード：MRC2102QY10825 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の下垂体ACTH分泌過多治療薬市場について種類別（AT-814、ATR-101、BIM-23A758、COR-005、CORT-125134、ISIS-GCCRRx、その他）、用途別（クリニック、病院、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・下垂体ACTH分泌過多治療薬市場の概要 ・世界の主要地域別下垂体ACTH分泌過多治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の下垂体ACTH分泌過多治療薬市場規模2015-2026：種類別（AT-814、ATR-101、BIM-23A758、COR-005、CORT-125134、ISIS-GCCRRx、その他） ・世界の下垂体ACTH分泌過多治療薬市場規模2015-2026：用途別（クリニック、病院、その他） ・下垂体ACTH分泌過多治療薬の米国市場規模2015-2020 ・下垂体ACTH分泌過多治療薬のヨーロッパ市場規模2015-2020 ・下垂体ACTH分泌過多治療薬の中国市場規模2015-2020 ・下垂体ACTH分泌過多治療薬の日本市場規模2015-2020 ・下垂体ACTH分泌過多治療薬の東南アジア市場規模2015-2020 ・下垂体ACTH分泌過多治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・下垂体ACTH分泌過多治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・下垂体ACTH分泌過多治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Pituitary ACTH Hypersecretion Drug Market
The global Pituitary ACTH Hypersecretion Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Pituitary ACTH Hypersecretion Drug Scope and Market Size
The global Pituitary ACTH Hypersecretion Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pituitary ACTH Hypersecretion Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Pituitary ACTH Hypersecretion Drug market is segmented into
AT-814
ATR-101
BIM-23A758
COR-005
CORT-125134
ISIS-GCCRRx
Others
Segment by Application, the Pituitary ACTH Hypersecretion Drug market is segmented into
Clinic
Hospital
Others
The Pituitary ACTH Hypersecretion Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Pituitary ACTH Hypersecretion Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pituitary ACTH Hypersecretion Drug Market Share Analysis
Pituitary ACTH Hypersecretion Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pituitary ACTH Hypersecretion Drug business, the date to enter into the Pituitary ACTH Hypersecretion Drug market, Pituitary ACTH Hypersecretion Drug product introduction, recent developments, etc.
The major vendors covered:
Alder Biopharmaceuticals Inc.
Corcept Therapeutics Incorporated
Cortendo AB
Cyclacel Pharmaceuticals, Inc.
ElexoPharm GmbH
Ipsen S.A.
Isis Pharmaceuticals, Inc.
Novartis AG
Orphagen Pharmaceuticals, Inc.
Pfizer Inc.
1 Pituitary ACTH Hypersecretion Drug Market Overview
1.1 Pituitary ACTH Hypersecretion Drug Product Scope
1.2 Pituitary ACTH Hypersecretion Drug Segment by Type
1.2.1 Global Pituitary ACTH Hypersecretion Drug Sales by Type (2020-2026)
1.2.2 AT-814
1.2.3 ATR-101
1.2.4 BIM-23A758
1.2.5 COR-005
1.2.6 CORT-125134
1.2.7 ISIS-GCCRRx
1.2.8 Others
1.3 Pituitary ACTH Hypersecretion Drug Segment by Application
1.3.1 Global Pituitary ACTH Hypersecretion Drug Sales Comparison by Application (2020-2026)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Pituitary ACTH Hypersecretion Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pituitary ACTH Hypersecretion Drug Sales Growth Rate (2015-2026)
1.4.2 Global Pituitary ACTH Hypersecretion Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Pituitary ACTH Hypersecretion Drug Price Trends (2015-2026)
2 Pituitary ACTH Hypersecretion Drug Estimate and Forecast by Region
2.1 Global Pituitary ACTH Hypersecretion Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pituitary ACTH Hypersecretion Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pituitary ACTH Hypersecretion Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Pituitary ACTH Hypersecretion Drug Revenue Market Share by Region (2015-2020)
2.3 Global Pituitary ACTH Hypersecretion Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pituitary ACTH Hypersecretion Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pituitary ACTH Hypersecretion Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
2.4.2 Europe Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
2.4.3 China Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
2.4.4 Japan Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
2.4.6 India Pituitary ACTH Hypersecretion Drug Estimates and Projections (2015-2026)
3 Global Pituitary ACTH Hypersecretion Drug Competition Landscape by Players
3.1 Global Top Pituitary ACTH Hypersecretion Drug Players by Sales (2015-2020)
3.2 Global Top Pituitary ACTH Hypersecretion Drug Players by Revenue (2015-2020)
3.3 Global Pituitary ACTH Hypersecretion Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pituitary ACTH Hypersecretion Drug as of 2019)
3.4 Global Pituitary ACTH Hypersecretion Drug Average Price by Company (2015-2020)
3.5 Manufacturers Pituitary ACTH Hypersecretion Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pituitary ACTH Hypersecretion Drug Players (Opinion Leaders)
4 Global Pituitary ACTH Hypersecretion Drug Market Size by Type
4.1 Global Pituitary ACTH Hypersecretion Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Pituitary ACTH Hypersecretion Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Pituitary ACTH Hypersecretion Drug Price by Type (2015-2020)
4.2 Global Pituitary ACTH Hypersecretion Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pituitary ACTH Hypersecretion Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pituitary ACTH Hypersecretion Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Pituitary ACTH Hypersecretion Drug Price Forecast by Type (2021-2026)
5 Global Pituitary ACTH Hypersecretion Drug Market Size by Application
5.1 Global Pituitary ACTH Hypersecretion Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Pituitary ACTH Hypersecretion Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Pituitary ACTH Hypersecretion Drug Price by Application (2015-2020)
5.2 Global Pituitary ACTH Hypersecretion Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pituitary ACTH Hypersecretion Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pituitary ACTH Hypersecretion Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pituitary ACTH Hypersecretion Drug Price Forecast by Application (2021-2026)
6 United States Pituitary ACTH Hypersecretion Drug Market Facts & Figures
6.1 United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
6.2 United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
6.3 United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
7 Europe Pituitary ACTH Hypersecretion Drug Market Facts & Figures
7.1 Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
7.2 Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
7.3 Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
8 China Pituitary ACTH Hypersecretion Drug Market Facts & Figures
8.1 China Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
8.2 China Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
8.3 China Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
9 Japan Pituitary ACTH Hypersecretion Drug Market Facts & Figures
9.1 Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (3015-3030)
9.2 Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
9.3 Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Pituitary ACTH Hypersecretion Drug Market Facts & Figures
10.1 Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
11 India Pituitary ACTH Hypersecretion Drug Market Facts & Figures
11.1 India Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
11.2 India Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
11.3 India Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pituitary ACTH Hypersecretion Drug Business
12.1 Alder Biopharmaceuticals Inc.
12.1.1 Alder Biopharmaceuticals Inc. Corporation Information
12.1.2 Alder Biopharmaceuticals Inc. Business Overview
12.1.3 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Products Offered
12.1.5 Alder Biopharmaceuticals Inc. Recent Development
12.2 Corcept Therapeutics Incorporated
12.2.1 Corcept Therapeutics Incorporated Corporation Information
12.2.2 Corcept Therapeutics Incorporated Business Overview
12.2.3 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Products Offered
12.2.5 Corcept Therapeutics Incorporated Recent Development
12.3 Cortendo AB
12.3.1 Cortendo AB Corporation Information
12.3.2 Cortendo AB Business Overview
12.3.3 Cortendo AB Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cortendo AB Pituitary ACTH Hypersecretion Drug Products Offered
12.3.5 Cortendo AB Recent Development
12.4 Cyclacel Pharmaceuticals, Inc.
12.4.1 Cyclacel Pharmaceuticals, Inc. Corporation Information
12.4.2 Cyclacel Pharmaceuticals, Inc. Business Overview
12.4.3 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Products Offered
12.4.5 Cyclacel Pharmaceuticals, Inc. Recent Development
12.5 ElexoPharm GmbH
12.5.1 ElexoPharm GmbH Corporation Information
12.5.2 ElexoPharm GmbH Business Overview
12.5.3 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Products Offered
12.5.5 ElexoPharm GmbH Recent Development
12.6 Ipsen S.A.
12.6.1 Ipsen S.A. Corporation Information
12.6.2 Ipsen S.A. Business Overview
12.6.3 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ipsen S.A. Pituitary ACTH Hypersecretion Drug Products Offered
12.6.5 Ipsen S.A. Recent Development
12.7 Isis Pharmaceuticals, Inc.
12.7.1 Isis Pharmaceuticals, Inc. Corporation Information
12.7.2 Isis Pharmaceuticals, Inc. Business Overview
12.7.3 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Products Offered
12.7.5 Isis Pharmaceuticals, Inc. Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Corporation Information
12.8.2 Novartis AG Business Overview
12.8.3 Novartis AG Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Novartis AG Pituitary ACTH Hypersecretion Drug Products Offered
12.8.5 Novartis AG Recent Development
12.9 Orphagen Pharmaceuticals, Inc.
12.9.1 Orphagen Pharmaceuticals, Inc. Corporation Information
12.9.2 Orphagen Pharmaceuticals, Inc. Business Overview
12.9.3 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Products Offered
12.9.5 Orphagen Pharmaceuticals, Inc. Recent Development
12.10 Pfizer Inc.
12.10.1 Pfizer Inc. Corporation Information
12.10.2 Pfizer Inc. Business Overview
12.10.3 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Pfizer Inc. Pituitary ACTH Hypersecretion Drug Products Offered
12.10.5 Pfizer Inc. Recent Development
13 Pituitary ACTH Hypersecretion Drug Manufacturing Cost Analysis
13.1 Pituitary ACTH Hypersecretion Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pituitary ACTH Hypersecretion Drug
13.4 Pituitary ACTH Hypersecretion Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pituitary ACTH Hypersecretion Drug Distributors List
14.3 Pituitary ACTH Hypersecretion Drug Customers
15 Market Dynamics
15.1 Pituitary ACTH Hypersecretion Drug Market Trends
15.2 Pituitary ACTH Hypersecretion Drug Opportunities and Drivers
15.3 Pituitary ACTH Hypersecretion Drug Market Challenges
15.4 Pituitary ACTH Hypersecretion Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Pituitary ACTH Hypersecretion Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Pituitary ACTH Hypersecretion Drug Sales Market Share by Region (2015-2020)
Table 6. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Region (2015-2020)
Table 8. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Pituitary ACTH Hypersecretion Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pituitary ACTH Hypersecretion Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pituitary ACTH Hypersecretion Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Pituitary ACTH Hypersecretion Drug Sales Share by Company (2015-2020)
Table 14. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Company (2015-2020)
Table 16. Global Pituitary ACTH Hypersecretion Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pituitary ACTH Hypersecretion Drug as of 2019)
Table 17. Global Pituitary ACTH Hypersecretion Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Pituitary ACTH Hypersecretion Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Pituitary ACTH Hypersecretion Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pituitary ACTH Hypersecretion Drug Players
Table 22. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Pituitary ACTH Hypersecretion Drug Sales Share by Type (2015-2020)
Table 24. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pituitary ACTH Hypersecretion Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Pituitary ACTH Hypersecretion Drug Sales Share by Type (2021-2026)
Table 27. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Type (2021-2026)
Table 29. Global Pituitary ACTH Hypersecretion Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Pituitary ACTH Hypersecretion Drug Sales Share by Application (2015-2020)
Table 32. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pituitary ACTH Hypersecretion Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Pituitary ACTH Hypersecretion Drug Sales Share by Application (2021-2026)
Table 36. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Application (2021-2026)
Table 38. Global Pituitary ACTH Hypersecretion Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 41. United States Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 43. United States Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 51. China Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 53. China Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 55. China Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
Table 69. India Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Company (2015-2020)
Table 71. India Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Type (2015-2020)
Table 73. India Pituitary ACTH Hypersecretion Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Application (2015-2020)
Table 75. Alder Biopharmaceuticals Inc. Corporation Information
Table 76. Alder Biopharmaceuticals Inc. Description and Business Overview
Table 77. Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Alder Biopharmaceuticals Inc. Pituitary ACTH Hypersecretion Drug Product
Table 79. Alder Biopharmaceuticals Inc. Recent Development
Table 80. Corcept Therapeutics Incorporated Corporation Information
Table 81. Corcept Therapeutics Incorporated Description and Business Overview
Table 82. Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Corcept Therapeutics Incorporated Pituitary ACTH Hypersecretion Drug Product
Table 84. Corcept Therapeutics Incorporated Recent Development
Table 85. Cortendo AB Corporation Information
Table 86. Cortendo AB Description and Business Overview
Table 87. Cortendo AB Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Cortendo AB Pituitary ACTH Hypersecretion Drug Product
Table 89. Cortendo AB Recent Development
Table 90. Cyclacel Pharmaceuticals, Inc. Corporation Information
Table 91. Cyclacel Pharmaceuticals, Inc. Description and Business Overview
Table 92. Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Cyclacel Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product
Table 94. Cyclacel Pharmaceuticals, Inc. Recent Development
Table 95. ElexoPharm GmbH Corporation Information
Table 96. ElexoPharm GmbH Description and Business Overview
Table 97. ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. ElexoPharm GmbH Pituitary ACTH Hypersecretion Drug Product
Table 99. ElexoPharm GmbH Recent Development
Table 100. Ipsen S.A. Corporation Information
Table 101. Ipsen S.A. Description and Business Overview
Table 102. Ipsen S.A. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Ipsen S.A. Pituitary ACTH Hypersecretion Drug Product
Table 104. Ipsen S.A. Recent Development
Table 105. Isis Pharmaceuticals, Inc. Corporation Information
Table 106. Isis Pharmaceuticals, Inc. Description and Business Overview
Table 107. Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Isis Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product
Table 109. Isis Pharmaceuticals, Inc. Recent Development
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Novartis AG Description and Business Overview
Table 113. Novartis AG Pituitary ACTH Hypersecretion Drug Product
Table 114. Novartis AG Recent Development
Table 115. Orphagen Pharmaceuticals, Inc. Corporation Information
Table 116. Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Orphagen Pharmaceuticals, Inc. Description and Business Overview
Table 118. Orphagen Pharmaceuticals, Inc. Pituitary ACTH Hypersecretion Drug Product
Table 119. Orphagen Pharmaceuticals, Inc. Recent Development
Table 120. Pfizer Inc. Corporation Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Pituitary ACTH Hypersecretion Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Pfizer Inc. Pituitary ACTH Hypersecretion Drug Product
Table 124. Pfizer Inc. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Pituitary ACTH Hypersecretion Drug Distributors List
Table 128. Pituitary ACTH Hypersecretion Drug Customers List
Table 129. Pituitary ACTH Hypersecretion Drug Market Key Trends
Table 130. Pituitary ACTH Hypersecretion Drug Key Opportunities and Drivers
Table 131. Pituitary ACTH Hypersecretion Drug Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Pituitary ACTH Hypersecretion Drug Product Picture
Figure 2. Global Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pituitary ACTH Hypersecretion Drug Market Share by Application in 2020 & 2026
Figure 6. Clinic Examples
Figure 7. Hospital Examples
Figure 8. Others Examples
Figure 9. Global Pituitary ACTH Hypersecretion Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Pituitary ACTH Hypersecretion Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pituitary ACTH Hypersecretion Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Pituitary ACTH Hypersecretion Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pituitary ACTH Hypersecretion Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pituitary ACTH Hypersecretion Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pituitary ACTH Hypersecretion Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pituitary ACTH Hypersecretion Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pituitary ACTH Hypersecretion Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pituitary ACTH Hypersecretion Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pituitary ACTH Hypersecretion Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pituitary ACTH Hypersecretion Drug Players Market Share by Revenue in Pituitary ACTH Hypersecretion Drug 2015 & 2019
Figure 27. Pituitary ACTH Hypersecretion Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Type (2015-2020)
Figure 29. Global Pituitary ACTH Hypersecretion Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pituitary ACTH Hypersecretion Drug Revenue Share by Application (2015-2020)
Figure 31. Global Pituitary ACTH Hypersecretion Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 33. United States Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 34. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Company in 2019
Figure 35. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 36. Europe Pituitary ACTH Hypersecretion Drug Sales Market Share by Application in 2019
Figure 37. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Company in 2019
Figure 38. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 39. China Pituitary ACTH Hypersecretion Drug Sales Market Share by Application in 2019
Figure 40. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Company in 2019
Figure 41. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 42. Japan Pituitary ACTH Hypersecretion Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pituitary ACTH Hypersecretion Drug Sales Market Share by Application in 2019
Figure 46. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Company in 2019
Figure 47. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Type in 2019
Figure 48. India Pituitary ACTH Hypersecretion Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Pituitary ACTH Hypersecretion Drug
Figure 51. Manufacturing Process Analysis of Pituitary ACTH Hypersecretion Drug
Figure 52. Pituitary ACTH Hypersecretion Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
I型高脂血症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Type I Hyperlipoproteinemia Drug Market The global Type I Hyperlipoproteinemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Type I Hyperlipoproteinemia Drug Scope and Market …- 耳鳴症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Tinnitus Drug Market The global Tinnitus Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tinnitus Drug Scope and Market Size The global Tinnitus Drug market is segmented by comp…
- 原発性高シュウ酸尿症薬の世界市場レポート2020 Market Analysis and Insights: Global Primary Hyperoxaluria Drug Market The global Primary Hyperoxaluria Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Primary Hyperoxaluria Drug Scope and Market Size The global Pr…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …